Evidence map›Paper›PMID 31323240›Full record

ArticleNeurotoxicology2019

Strengths and limitations of morphological and behavioral analyses in detecting dopaminergic deficiency in Caenorhabditis elegans.

Latasha L Smith, Ian T Ryde, Jessica H Hartman, Riccardo F Romersi, Zachary Markovich, Joel N Meyer

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Rescue of a Rotenone Model of Parkinson's Disease inInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Latasha L SmithDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, United States; Integrated Toxicology and Environmental Health Program, Duke University, Durham, NC, United States. Electronic address: latasha.l.smith@duke.edu.
Ian T RydeIntegrated Toxicology and Environmental Health Program, Duke University, Durham, NC, United States; Nicholas School of the Environment, Duke University, Durham, NC, United States. Electronic address: ian.ryde@duke.edu.
Jessica H HartmanNicholas School of the Environment, Duke University, Durham, NC, United States. Electronic address: jessica.h.hartman@duke.edu.
Riccardo F RomersiNicholas School of the Environment, Duke University, Durham, NC, United States. Electronic address: riccardo.romersi@duke.edu.
Zachary MarkovichNicholas School of the Environment, Duke University, Durham, NC, United States. Electronic address: zachary.markovich@duke.edu.
Joel N MeyerIntegrated Toxicology and Environmental Health Program, Duke University, Durham, NC, United States; Nicholas School of the Environment, Duke University, Durham, NC, United States. Electronic address: joel.meyer@duke.edu.
Duke University · US

Funding

Zebrafish as a Detector of Organophosphate ExposureP42ES010356 · NIEHS · DUKE UNIVERSITY · PI AMY H HERRING · 2000 to 2026
$56.2M
Pharmacological Sciences Training ProgramT32GM007105 · NIGMS · DUKE UNIVERSITY · PI KUHN, CYNTHIA M · 1985 to 2019
$9.0M
The Role of Mitochondrial DNA Damage in NeurodegenerationR01ES017540 · NIEHS · DUKE UNIVERSITY · PI MEYER, JOEL NEWMAN · 2011 to 2015
$1.8M
Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven NeurodegenerationF32ES027306 · NIEHS · DUKE UNIVERSITY · PI HARTMAN, JESSICA HELENE · 2016 to 2018
$171k
NIEHS NIH HHS F32 ES027306NIEHS NIH HHS P42 ES010356NIEHS NIH HHS R01 ES017540NIGMS NIH HHS T32 GM007105
6 · The paper itself

Abstract

In order to develop a better understanding of the role environmental toxicants may play in the onset and progression of neurodegenerative diseases, it has become increasingly important to optimize sensitive methods for quickly screening toxicants to determine their ability to disrupt neuronal function. The nematode Caenorhabditis elegans can help with this effort. This species has an integrated nervous system producing behavioral function, provides easy access for molecular studies, has a rapid lifespan, and is an inexpensive model. This study focuses on methods of measuring neurodegeneration involving the dopaminergic system and the identification of compounds with actions that disrupt dopamine function in the model organism C. elegans. Several dopamine-mediated locomotory behaviors, Area Exploration, Body Bends, and Reversals, as well as Swimming-Induced Paralysis and Learned 2-Nonanone Avoidance, were compared to determine the best behavioral method for screening purposes. These behavioral endpoints were also compared to morphological scoring of neurodegeneration in the dopamine neurons. We found that in adult worms, Area Exploration is more advantageous than the other behavioral methods for identifying DA-deficient locomotion and is comparable to neuromorphological scoring outputs. For larval stage worms, locomotion was an unreliable endpoint, and neuronal scoring appeared to be the best method. We compared the wild-type N2 strain to the commonly used dat-1p::GFP reporter strains BY200 and BZ555, and we further characterized the dopamine-deficient strains, cat-2 e1112 and cat-2 n4547. In contrast to published results, we found that the cat-2 strains slowed on food almost as much as N2s. Both showed decreased levels of cat-2 mRNA and DA content, rather than none, with cat-2 e1112 having the greatest reduction in DA content in comparison to N2. Finally, we compared and contrasted strengths, limitations, cost, and equipment needs for all primary methods for analysis of the dopamine system in C. elegans.

Indexed as

Caenorhabditis elegansAnimalsAnimals, Genetically ModifiedAvoidance LearningBehavior, AnimalCaenorhabditis elegans ProteinsCationic Amino Acid Transporter 2DopamineDopaminergic NeuronsExploratory BehaviorGene Expression RegulationHydroxydopaminesLarvaLocomotionNeurodegenerative DiseasesCaenorhabditis elegans ProteinsCationic Amino Acid Transporter 2DopamineHydroxydopaminesBehaviorcat-2C. elegansDopamineLocomotionNeurodegeneration

Identifiers

PMID31323240
PMCPMC6751008
OpenAlexW2962327914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.